Anatomic Pathology Track and Trace Solutions Market 2019 Precise Outlook

07.11.2019 - 10:50 | 1768605

Artikel von marketsandmarkets

The anatomic pathology track and trace solutions market is projected to reach USD 695.7 million by 2023 from USD 424.2 million in 2018, at a CAGR of 10.4%

According to the new market research report "Anatomic Pathology Track and Trace Solutions Market by Product (Software, Hardware (Printer & Labeling Systems), Consumables), Technology (Barcode, RFID), Application (Tissue Cassette, Slide Tracking), End User (Hospital Labs) - Global Forecast to 2023", published by MarketsandMarkets™,

The increasing volume of diagnostic tests performed in anatomic pathology laboratories and the increasing number of legal cases around cancer misdiagnosis are the major factors driving the growth of this market. Also, the integration of laboratory information systems with track and trace pathology systems is expected to offer significant growth opportunities for leading players operating in the market in the coming years.

Download PDF Brochure:

Software segment is expected to account for the largest share of the anatomic pathology track and trace solutions market, by product, in 2018

On the basis of product, the market is broadly segmented into software, hardware, and consumables. In 2018, the software segment is expected to account for the largest share of this market. This can majorly be attributed to the growing need to automate the sample labeling process for reducing manual errors, increasing focus on improving the efficiency of anatomic laboratories, growing adoption of cloud-based LIMS, and the increasing workload in anatomic pathology laboratories.

Browse and in-depth TOC on "Anatomic Pathology Track and Trace Solutions Market"

112 - Tables
34 - Figures
164 - Pages

Barcode segment is expected to account for the largest share of the anatomic pathology track and trace solutions market, by technology, in 2018

On the basis of technology, the market is segmented into barcode and RFID. In 2018, the barcode segment is expected to account for a larger share of the market majorly due to the higher adoption of barcode systems among end users owing to their lower cost (as compared to RFID).

North America is expected to dominate the market in 2018

North America is expected to account for the largest share of the market in 2018, followed by Europe. The increasing volume of diagnostic tests performed in anatomic pathology laboratories, easy accessibility to advanced technologies, growing demand for advanced cancer diagnostic testing and screening, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the strong presence of leading market players in the region are the major factors responsible for the large share of North America in the market.

Request Research Sample Pages:

The key players operating in the global anatomic pathology track and trace solutions market are Thermo Fisher Scientific (US), Leica Biosystems (Germany), General Data Healthcare (US), Ventana Medical Systems (US), Agilent Technologies (US), Sunquest Information Systems (US), Zebra Technologies Corporation (US), Primera Technology (US), Cerebrum Corporation (US), AP Easy Software Solutions (US), and LigoLab (US).

Unternehmensinformation / Kurzprofil:

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales(at)
Visit Our Website:

PresseKontakt / Agentur:



Vor- / Nachname: marketsandmarkets

Ansprechpartner: shelly singh
Stadt: northbook
Telefon: 8886006441

Keywords (optional):
anatomic-pathology-track-and-trace-solutions, track-and-trace-solutions, anatomic-pathology,

Dieser Artikel wurde bisher 42 mal aufgerufen.


Direkter Link zu diesem Artikel:

Diese Pressemeldung bookmarken bei...

Tausendreporter BlinkList Folkd Furl Google Linkarena Mister Wong oneview Yahoo MyWeb YiGG Webnews Technorati

Über einen Link auf Ihrer News-, Presse- oder Partner-Seite würden wir uns sehr freuen.

Hiermit versichert der Erfasser, dass der eingestellte Artikel der Wahrheit entspricht. Er ist frei von Rechten Dritter und steht zur Veröffentlichung bereit. Die Haftung für eventuelle Folgen (z.B. Abmahnungen, Schadenersatzforderungen etc.) übernimmt der Eintrager und nicht

[ Anfrage per Mail | Fehlerhaften Artikel melden | Druckbare Version | Diesen Artikel an einen Freund senden ]

Alle Artikel von marketsandmarkets RSS Feed

Accord und ADIENNE schließen exklusiven Vertriebsvertrag für TEPADINA® ab
Asia Pacific Animal Health Market Trends Estimates High Demand by 2021
Mallinckrodt gibt bekannt, dass UVADEX® (Methoxsalen) in Australien für die Verwendung mit dem THERAKOS® CELLEX® Photopheresesystem für die Behandlung der chronischen Graft-versus-Host-Reaktion (cGvHR) und Hautmanifestationen von kutanen T-Zell Lympho...
3D Cell Culture Market : Regenerative Medicine to Offer Global Growth In Coming Years
Seno Medical und "Know Your Lemons" unterstreichen, welche wichtige Rolle Aufklärung und Selbstuntersuchung im Bereich der Früherkennung von Brustkrebs spielen

Blogverzeichnis - Blog Verzeichnis bloggerei.deBlog Top Liste - by